Tackling Infectious Diseases with Rapid Molecular Diagnosis and Innovative Prevention.
Rabeea F OmarMaurice BoissinotAnn HuletskyMichel G BergeronPublished in: Infectious disease reports (2024)
Infectious diseases (IDs) are a leading cause of death. The diversity and adaptability of microbes represent a continuing risk to health. Combining vision with passion, our transdisciplinary medical research team has been focussing its work on the better management of infectious diseases for saving human lives over the past five decades through medical discoveries and innovations that helped change the practice of medicine. The team used a multiple-faceted and integrated approach to control infectious diseases through fundamental discoveries and by developing innovative prevention tools and rapid molecular diagnostic tests to fulfill the various unmet needs of patients and health professionals in the field of ID. In this article, as objectives, we put in context two main research areas of ID management: innovative infection prevention that is woman-controlled, and the rapid molecular diagnosis of infection and resistance. We also explain how our transdisciplinary approach encompassing specialists from diverse fields ranging from biology to engineering was instrumental in achieving success. Furthermore, we discuss our vision of the future for translational research to better tackle IDs.
Keyphrases
- infectious diseases
- healthcare
- end stage renal disease
- loop mediated isothermal amplification
- endothelial cells
- palliative care
- newly diagnosed
- ejection fraction
- primary care
- chronic kidney disease
- public health
- single molecule
- mental health
- risk assessment
- prognostic factors
- current status
- social media
- human health
- quantum dots
- medical education
- breast cancer risk